CN105879212A - 一种心脑血管疾病专用治疗仪 - Google Patents
一种心脑血管疾病专用治疗仪 Download PDFInfo
- Publication number
- CN105879212A CN105879212A CN201610234242.6A CN201610234242A CN105879212A CN 105879212 A CN105879212 A CN 105879212A CN 201610234242 A CN201610234242 A CN 201610234242A CN 105879212 A CN105879212 A CN 105879212A
- Authority
- CN
- China
- Prior art keywords
- cardiovascular
- medicine
- cerebrovascular disease
- steam
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 35
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 30
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 29
- 230000001225 therapeutic effect Effects 0.000 title abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 69
- 210000000582 semen Anatomy 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 7
- 241000237903 Hirudo Species 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 239000000284 extract Substances 0.000 claims description 5
- 238000003825 pressing Methods 0.000 claims description 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 4
- 241000756943 Codonopsis Species 0.000 claims description 4
- 241000218628 Ginkgo Species 0.000 claims description 4
- 235000011201 Ginkgo Nutrition 0.000 claims description 4
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 4
- 241000218093 Phedimus aizoon Species 0.000 claims description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 4
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000000470 constituent Substances 0.000 claims description 3
- 230000007812 deficiency Effects 0.000 claims description 3
- 238000009413 insulation Methods 0.000 claims description 3
- 230000007246 mechanism Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 claims description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 2
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 claims description 2
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 claims description 2
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 2
- 229960000304 folic acid Drugs 0.000 claims description 2
- 235000019152 folic acid Nutrition 0.000 claims description 2
- 239000011724 folic acid Substances 0.000 claims description 2
- 229940067606 lecithin Drugs 0.000 claims description 2
- 235000010445 lecithin Nutrition 0.000 claims description 2
- 239000000787 lecithin Substances 0.000 claims description 2
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 claims description 2
- 229920002414 procyanidin Polymers 0.000 claims description 2
- 229960001471 sodium selenite Drugs 0.000 claims description 2
- 235000015921 sodium selenite Nutrition 0.000 claims description 2
- 239000011781 sodium selenite Substances 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 1
- 229930003471 Vitamin B2 Natural products 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- 229960002477 riboflavin Drugs 0.000 claims 1
- 239000011716 vitamin B2 Substances 0.000 claims 1
- 235000019164 vitamin B2 Nutrition 0.000 claims 1
- 239000007788 liquid Substances 0.000 description 36
- 239000007787 solid Substances 0.000 description 28
- 239000007789 gas Substances 0.000 description 9
- 230000035807 sensation Effects 0.000 description 6
- 235000019615 sensations Nutrition 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 230000036760 body temperature Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000002070 germicidal effect Effects 0.000 description 4
- 238000000889 atomisation Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 208000018152 Cerebral disease Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 240000002853 Nelumbo nucifera Species 0.000 description 2
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010061751 Cerebrovascular stenosis Diseases 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 108010061435 Enalapril Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 208000018569 Respiratory Tract disease Diseases 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- -1 and through test Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 1
- 229960000873 enalapril Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000002640 oxygen therapy Methods 0.000 description 1
- 230000001314 paroxysmal effect Effects 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/41—Crassulaceae (Stonecrop family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
- A61K36/725—Ziziphus, e.g. jujube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
一种心脑血管疾病专用治疗仪,其特征在于,所述心脑血管疾病专用治疗仪具有一蒸汽发生器,所述蒸汽发生器通过导气管输出蒸汽并连接至药物腔,所述药物腔通过一药气输出管连接至喷出头,所述喷出头设计为可贴近人体的形状。
Description
技术领域
本发明涉及一种心脑血管疾病专用治疗仪,属于心脑血管科治疗的技术领域。
背景技术
心脑血管疾病是一种严重威胁人类,特别是50岁以上中老年人健康的常见病,具有高患病率、高致残率和高死亡率的特点,即使应用目前最先进、完善的治疗手段,仍可有50%以上的脑血管意外幸存者生活不能完全自理,全世界每年死于心脑血管疾病的人数高达1500万人,居各种死因首位。目前,人们通常采取每年定期到医院采用输液方式疏通血管,试图减少或避免血栓性疾病的发生,但是输液治疗对身体副作用较大,而且治疗费用较高,治疗效果不明显。
现有技术中针对心脑血管疾病有一种中医药氧疗法。把药物制剂放入“医用雾化药氧治疗仪”,经过雾化,同时通入适量的氧气,患者做吸入治疗,通过呼吸道和肺泡吸收治疗疾病,其所使用的药物分为:舒心氧药:雾化药物由瓜蒌、红花、西洋参等组成,主要用于治疗冠心病、心功能不全、肺心病。脑心氧药:雾化药物由黄芪、当归、西洋参、熟大黄等组成,主要用于治疗脑梗塞、脑血栓、高血压病。肺心氧药:由西洋参、麻黄、川贝等组成,主要用于治疗支气管哮喘、急慢性支气管炎、支气管扩张、肺气肿等病症。
然而,由于心脑疾病患者的特殊性,采用雾化方式治疗有很大的负面效果,其中之一就是心脑血管患者在长时间呼吸闷湿环境下可能会加重病情,甚至引发突发性的病情发作,并且,由于中草药往往有令人难以忍受的异味,造成治疗过程比较痛苦,进而更加影响疗效。
发明内容
未解决上述技术问题,本发明提出一种心脑血管疾病专用治疗仪,其利用蒸汽带动药物的药理成分接触人体,从而对心脑血管起到辅助医疗作用,具体发明内容如下。
一种心脑血管疾病专用治疗仪,其特征在于,所述心脑血管疾病专用治疗仪具有一蒸汽发生器,所述蒸汽发生器通过导气管输出蒸汽并连接至药物腔,所述药物腔通过一药气输出管连接至喷出头,所述喷出头设计为可贴近人体的形状。
优选的,所述蒸汽发生器具有顶部的水箱和底部的蒸汽腔,所述蒸汽腔和水箱之间的通口通过水位开关开启或关闭,所述蒸汽腔的底部设置有加热体,且在蒸汽腔的底表面上设置有隔热层;所述蒸汽腔的出口连接所述导气管,所述导气管的另一侧连接至药物腔,且在所述导气管与所述药物腔连接的位置具有在一定蒸汽压力下才会开启的压力阀;
所述药物腔在整个横截面方向上设置有一个药物包,所述药物包由透气材料制成,其内部成装有治疗心脑血管疾病的药物,蒸汽通过所述药物包后变成具有药物活性成分的药气,通过所述药气输出管到达所述喷出头,所述喷出头的表面为可接触人体的柔性结构。
优选的,所述喷出头的两侧具有带孔,所述带孔上各设置有至少一部分为弹性结构的绑带,两个绑带的末端具有可卡接固定的卡扣,并且至少一个绑带上具有调节长度的机构。
优选的,所述蒸汽腔内具有在蒸汽力量不足时可以开启的加压风扇。
优选的,所述药物腔内盛装的药物为:按重量份,金钱草5-10份,丹参20-30份,莲子30-40份,川芎10-15份、冰片30-40份,红花15-25份,酸枣仁30-40份,芥子20-30份,木瓜15-25份,钩藤10-30份,白果15-30份,党参10-30份,白芍20-25份,水蛭提取物粉末5-10份,丹参30-40份,黄芪10-15份,天麻10-30份,何首乌5-10份,枸杞10-15份,山楂干20-30份,狗尾草5-10份,养心草20-30份和松叶5-15份;将上述重量份的药物混合后,利用粉碎机打成尺寸不大于0.3厘米的颗粒,搅拌均匀混合后装入所述药物包中,所述药物包上具有可固定在所述药物腔上的固定装置。
优选,上述药物还可以具有原花青素5-10份、亚硒酸钠10-15份、维生素A1-5份、维生素B2 5-15份、叶酸5-20份、卵磷脂5-10份、L-肉碱1-5份。
优选的,所述心脑血管疾病专用治疗仪还包括负载所述蒸汽发生器的推车系统,包括车架、万向滚轮和推车手柄,其具体结构为:
所述车架上部设置有输液杆和顶板,所述输液杆可伸缩安装在所述顶板的一角上,在所述顶板的下方水平相邻设有药品放置箱和文档箱,在所述文档箱下方设有储藏室,在所述药品放置箱下方上下设置保温室和冷藏室,所述滚轮上设有减震系统,所述储藏室室内设有紫外线杀菌灯,所述紫外线杀菌灯顶部设有蓄电池,所述蓄电池一侧设有电源接口;
所述储藏室,保温室和冷藏室水平相邻设置,且在它们下方具有水平相邻设置的固体垃圾箱和液体垃圾箱,所述固体垃圾箱和液体垃圾箱均具有箱门,其中所述液体垃圾箱具有液体垃圾倒入口,液体垃圾管道和液体垃圾容器,所述液体垃圾倒入口设置于所述推车系统顶部的顶板上,所述液体垃圾容器设置于所述液体垃圾箱内,所述液体垃圾容器通过所述液体垃圾管道与所述液体垃圾倒入口连接;
所述固体垃圾箱包括设置于顶板上的固体垃圾投入口,所述固体垃圾投入口,固体垃圾管道和固体垃圾容器,所述液体垃圾容器设置于所述液体垃圾箱内,所述固体垃圾容器通过所述固体垃圾管道与所述固体垃圾投入口连接;所述固体垃圾投入口和液体垃圾倒入口均具有堵住口并可打开的舱盖;
所述车架的底部具有底座,所述底座具有六根条状的支撑杆,所述六根支撑杆排列为“日”字形,其中中间为两根相贴近设置的支撑杆,所述固体垃圾箱和液体垃圾箱设置在“日”字形的两个“口”字形结构内,其中支撑杆包裹所述固体垃圾箱和液体垃圾箱的外壳,并且两个“口”字形结构形成为上宽下窄的结构,而所述固体垃圾箱和液体垃圾箱的外壳也为上宽下窄的结构,从而套入到所述“口”字形结构中。
本发明的有益效果在于:使用蒸汽催动药力直接作用于皮肤,从而渗入人体取得药效,首先,避免了强湿度对于心脑血管病患者的影响,也避免了异味的影响,且经试验,药效比较有效,具有新颖性和创造性。
附图说明
附图1是本申请的心脑血管疾病专用治疗仪的结构示意图
其中附图标记1-蒸汽发生器,2-导气管,3-药物腔,4-药气输出管,5-喷出头,6-推车系统。
具体实施方式
下面详细描述本发明的实施例,所述实施例的示例在附图中示出,其中自始至终相同或类似的标号表示相同或类似的元件或具有相同或类似功能的元件。下面通过参考附图描述的实施例是示例性的,仅用于解释本发明,而不能理解为对本发明的限制。
一种心脑血管疾病专用治疗仪,其特征在于,所述心脑血管疾病专用治疗仪具有一蒸汽发生器1,所述蒸汽发生器1通过导气管2输出蒸汽并连接至药物腔3,所述药物腔3通过一药气输出管4连接至喷出头5,所述喷出头5设计为可贴近人体的形状。
优选的,所述蒸汽发生器2具有顶部的水箱和底部的蒸汽腔,所述蒸汽腔和水箱之间的通口通过水位开关开启或关闭,所述蒸汽腔的底部设置有加热体,且在蒸汽腔的底表面上设置有隔热层;所述蒸汽腔的出口连接所述导气管,所述导气管的另一侧连接至药物腔,且在所述导气管与所述药物腔连接的位置具有在一定蒸汽压力下才会开启的压力阀;
所述药物腔4在整个横截面方向上设置有一个药物包,所述药物包由透气材料制成,其内部成装有治疗心脑血管疾病的药物,蒸汽通过所述药物包后变成具有药物活性成分的药气,通过所述药气输出管到达所述喷出头,所述喷出头的表面为可接触人体的柔性结构。
优选的,所述喷出头5的两侧具有带孔,所述带孔上各设置有至少一部分为弹性结构的绑带,两个绑带的末端具有可卡接固定的卡扣,并且至少一个绑带上具有调节长度的机构。
优选的,所述蒸汽腔内具有在蒸汽力量不足时可以开启的加压风扇。
优选的,所述药物腔内盛装的药物为:按重量份,金钱草5-10份,丹参20-30份,莲子30-40份,川芎10-15份、冰片30-40份,红花15-25份,酸枣仁30-40份,芥子20-30份,木瓜15-25份,钩藤10-30份,白果15-30份,党参10-30份,白芍20-25份,水蛭提取物粉末5-10份,丹参30-40份,黄芪10-15份,天麻10-30份,何首乌5-10份,枸杞10-15份,山楂干20-30份,狗尾草5-10份,养心草20-30份和松叶5-15份;将上述重量份的药物混合后,利用粉碎机打成尺寸不大于0.3厘米的颗粒,搅拌均匀混合后装入所述药物包中,所述药物包上具有可固定在所述药物腔上的固定装置。
具体使用时,采取了金钱草8份,丹参20份,莲子40份,川芎15份、冰片40份,红花25份,酸枣仁30份,芥子20份,木瓜15份,钩藤10份,白果15份,党参10份,白芍20份,水蛭提取物粉末5份,丹参30份,黄芪10份,天麻10份,何首乌5份,枸杞10份,山楂干20份,狗尾草5份,养心草20份和松叶5份;水蛭提取物优选为水蛭唾液提取物,在以下病例取得显著疗效
病例一,耿某,女,60岁,山东省烟台市事业单位退休职工,2012年患心脑血管病,住院多次出院后不久仍心慌气短,经使用本治疗仪十五日后自身感觉好转,三个月后检查,原狭窄70%的心血管减少8%,又三个月后检查又减少10%,半年后检查减少12%,一年后心血管畅通,血压正常,至今未见复发。
病例二,陈某,男,40岁,青岛市某企业技术工作者,2013年患脑血管狭窄70%,经多次住院,出院不久仍心慌气短,右脸抖动,伴高血压,使用本治疗仪14日后感觉好转,一个月后不适症状明显消失,三个月后检查减少17%,半年后又减少19%,一年后又减少10%,如今未见复发。
病例三,郭某,男,46岁,烟台市技术工人,2010年患心血管病,狭窄49%,体重101公斤较胖,伴有“三高”,经常住院输液扩展血管,过后如是,胸闷气短。经用本治疗仪,三个月后不适症状消失,半年后经检查,狭窄减少9.7%,10个月后又减少10%,一年半后检查又减少11%,心血管狭窄基本正常,“三高”也有所缓解。
对比试验
选取各种心脑血管疾病患者,排除以下类型
1)皮肤过敏者;2) 具有慢性呼吸道疾病病史;3) 合并有心血管、肺、肝、肾、造血系统等严重疾病;4) 精神系统疾病患者;5) 对已知药物成分过敏者。
患者资料
病例选取 2013 年12月- 2015年7月来我院急诊就诊的 90例心脑疾病患者,随机分为3 组,治疗组30例,年龄 25~62岁,平均45.39岁 ,平均体温(37.3±0.6) ℃;对照1组30例,年龄30~62岁,平均43.84 岁,平均体温(37.2±0.7) ℃;对照2组30例,年龄30~61岁,平均42 岁,平均体温(37.2±0.7) ℃。3 组患者在性别、年龄、体温等方面比较差异无统计学意义( P > 0.05),具有可比性。
治疗方法
一般治疗
3组病人均嘱多休息,多饮水,密切观察病情变化。
药物治疗
对照1组:口服降压药,1 粒/ 次,每日 2 次,疗程 5 d。对照2组:口服红景天,1 粒/次,每日 2 次,疗程 5 d。治疗组:使用本发明的治疗仪,每日3次,每次14分钟,疗程5d。
观察方法
3 组均以5d 为1疗程,在观察期间,停用其他抗病毒、抗生素药物。观察 2 组用药 72h后症状体征。
疗效标准
临床治愈:经治 5 d 内,,且无反复,症状消失; 显效: 经治5 d,大热已退,体温接近37.0 ℃,主要症状大部分消失;有效:经治 5 d ,,主要症状部分消失;无效:经治5 d ,症状无明显改善。
统计学处理
数据处理应用专业统计软件SPSS12. 0 进行数据分析处理,细胞因子数据采用单因素方差分析,组间差异采用t 检验。
两组疗效比较,结果见表2。
表2 两组治疗72小时候疗效结果比较
| 组别 | 治愈 | 显效 | 有效 | 无效 | 总有效率 |
| 治疗组 | 18 | 9 | 3 | 0 | 100% |
| 对照1组 | 10 | 4 | 15 | 1 | 97% |
| 对照2组 | 12 | 5 | 11 | 2 | 93% |
优选的,所述心脑血管疾病专用治疗仪还包括负载所述蒸汽发生器的推车系统6,包括车架、万向滚轮和推车手柄,其具体结构为:
所述车架上部设置有输液杆和顶板,所述输液杆可伸缩安装在所述顶板的一角上,在所述顶板的下方水平相邻设有药品放置箱和文档箱,在所述文档箱下方设有储藏室,在所述药品放置箱下方上下设置保温室和冷藏室,所述滚轮上设有减震系统,所述储藏室室内设有紫外线杀菌灯,所述紫外线杀菌灯顶部设有蓄电池,所述蓄电池一侧设有电源接口;
所述储藏室,保温室和冷藏室水平相邻设置,且在它们下方具有水平相邻设置的固体垃圾箱和液体垃圾箱,所述固体垃圾箱和液体垃圾箱均具有箱门,其中所述液体垃圾箱具有液体垃圾倒入口,液体垃圾管道和液体垃圾容器,所述液体垃圾倒入口设置于所述推车系统顶部的顶板上,所述液体垃圾容器设置于所述液体垃圾箱内,所述液体垃圾容器通过所述液体垃圾管道与所述液体垃圾倒入口连接;
所述固体垃圾箱包括设置于顶板上的固体垃圾投入口,所述固体垃圾投入口,固体垃圾管道和固体垃圾容器,所述液体垃圾容器设置于所述液体垃圾箱内,所述固体垃圾容器通过所述固体垃圾管道与所述固体垃圾投入口连接;所述固体垃圾投入口和液体垃圾倒入口均具有堵住口并可打开的舱盖;
所述车架的底部具有底座,所述底座具有六根条状的支撑杆,所述六根支撑杆排列为“日”字形,其中中间为两根相贴近设置的支撑杆,所述固体垃圾箱和液体垃圾箱设置在“日”字形的两个“口”字形结构内,其中支撑杆包裹所述固体垃圾箱和液体垃圾箱的外壳,并且两个“口”字形结构形成为上宽下窄的结构,而所述固体垃圾箱和液体垃圾箱的外壳也为上宽下窄的结构,从而套入到所述“口”字形结构中。
在本发明的描述中,需要理解的是,术语“中心”、“上”、“下”、“前”、“后”、“左”、“右”、“竖直”、“水平”、“顶”、“底”、“内”、“外”、“径向”、“周向”等指示的方位或位置关系为基于附图所示的方位或位置关系,仅是为了便于描述本发明和简化描述,而不是指示或暗示所指的装置或元件必须具有特定的方位、以特定的方位构造和操作,因此不能理解为对本发明的限制。
此外,术语“第一”、“第二”仅用于描述目的,而不能理解为指示或暗示相对重要性或者隐含指明所指示的技术特征的数量。由此,限定有“第一”、“第二”的特征可以明示或者隐含地包括一个或者更多个该特征。在本发明的描述中,除非另有说明,“多个”的含义是两个或两个以上。
在本发明的描述中,需要说明的是,除非另有明确的规定和限定,术语“安装”、“相连”、“连接”应做广义理解,例如,可以是固定连接,也可以是可拆卸连接,或一体地连接;可以是直接相连,也可以通过中间媒介间接相连,可以是两个元件内部的连通。对于本领域的普通技术人员而言,可以具体情况理解上述术语在本发明中的具体含义。
下文的公开提供了许多不同的实施例或例子用来实现本发明的不同结构。为了简化本发明的公开,下文中对特定例子的部件和设置进行描述。当然,它们仅仅为示例,并且目的不在于限制本发明。此外,本发明可以在不同例子中重复参考数字和/或字母。这种重复是为了简化和清楚的目的,其本身不指示所讨论各种实施例和/或设置之间的关系。此外,本发明提供了的各种特定的工艺和材料的例子,但是本领域普通技术人员可以意识到其他工艺的可应用于性和/或其他材料的使用。
在本发明中,除非另有明确的规定和限定,第一特征在第二特征之“上”或之 “下”可以包括第一和第二特征直接接触,也可以包括第一和第二特征不是直接接触而是通过它们之间的另外的特征接触。
在本说明书的描述中,参考术语“一个实施例”、“一些实施例”、“示意性实施例”、“示例”、“具体示例”、或“一些示例”等的描述意指结合该实施例或示例描述的具体特征、结构、材料或者特点包含于本发明的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不一定指的是相同的实施例或示例。而且,描述的具体特征、结构、材料或者特点可以在任何的一个或多个实施例或示例中以合适的方式结合。
尽管已经示出和描述了本发明的实施例,本领域的普通技术人员可以理解:在不脱离本发明的原理和宗旨的情况下可以对这些实施例进行多种变化、修改、替换和变型,本发明的范围由权利要求及其等同物限定。
Claims (6)
1.一种心脑血管疾病专用治疗仪,其特征在于,所述心脑血管疾病专用治疗仪具有一蒸汽发生器,所述蒸汽发生器通过导气管输出蒸汽并连接至药物腔,所述药物腔通过一药气输出管连接至喷出头,所述喷出头设计为可贴近人体的形状。
2.根据权利要求1所述的心脑血管疾病专用治疗仪,其特征在于:所述蒸汽发生器具有顶部的水箱和底部的蒸汽腔,所述蒸汽腔和水箱之间的通口通过水位开关开启或关闭,所述蒸汽腔的底部设置有加热体,且在蒸汽腔的底表面上设置有隔热层;所述蒸汽腔的出口连接所述导气管,所述导气管的另一侧连接至药物腔,且在所述导气管与所述药物腔连接的位置具有在一定蒸汽压力下才会开启的压力阀;
所述药物腔在整个横截面方向上设置有一个药物包,所述药物包由透气材料制成,其内部成装有治疗心脑血管疾病的药物,蒸汽通过所述药物包后变成具有药物活性成分的药气,通过所述药气输出管到达所述喷出头,所述喷出头的表面为可接触人体的柔性结构。
3.根据权利要求1所述的心脑血管疾病专用治疗仪,其特征在于:所述喷出头的两侧具有带孔,所述带孔上各设置有至少一部分为弹性结构的绑带,两个绑带的末端具有可卡接固定的卡扣,并且至少一个绑带上具有调节长度的机构。
4.根据权利要求1所述的心脑血管疾病专用治疗仪,其特征在于:所述蒸汽腔内具有在蒸汽力量不足时可以开启的加压风扇。
5.根据权利要求1所述的心脑血管疾病专用治疗仪,其特征在于:所述药物腔内盛装的药物为:按重量份,金钱草5-10份,丹参20-30份,莲子30-40份,川芎10-15份、冰片30-40份,红花15-25份,酸枣仁30-40份,芥子20-30份,木瓜15-25份,钩藤10-30份,白果15-30份,党参10-30份,白芍20-25份,水蛭提取物粉末5-10份,丹参30-40份,黄芪10-15份,天麻10-30份,何首乌5-10份,枸杞10-15份,山楂干20-30份,狗尾草5-10份,养心草20-30份和松叶5-15份;将上述重量份的药物混合后,利用粉碎机打成尺寸不大于0.3厘米的颗粒,搅拌均匀混合后装入所述药物包中,所述药物包上具有可固定在所述药物腔上的固定装置。
6.根据权利要求1所述的心脑血管疾病专用治疗仪,其特征在于:上述药物还可以具有原花青素5-10份、亚硒酸钠10-15份、维生素A1-5份、维生素B2 5-15份、叶酸5-20份、卵磷脂5-10份、L-肉碱1-5份。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610234242.6A CN105879212A (zh) | 2016-04-17 | 2016-04-17 | 一种心脑血管疾病专用治疗仪 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610234242.6A CN105879212A (zh) | 2016-04-17 | 2016-04-17 | 一种心脑血管疾病专用治疗仪 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105879212A true CN105879212A (zh) | 2016-08-24 |
Family
ID=56703932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610234242.6A Pending CN105879212A (zh) | 2016-04-17 | 2016-04-17 | 一种心脑血管疾病专用治疗仪 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105879212A (zh) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2553814Y (zh) * | 2002-07-22 | 2003-06-04 | 杨如明 | 可控式中药蒸发治疗仪 |
| JP2006174896A (ja) * | 2004-12-21 | 2006-07-06 | Matsushita Electric Ind Co Ltd | 酸素富化機 |
| CN201192455Y (zh) * | 2008-05-15 | 2009-02-11 | 于守杰 | 一种蒸汽型风湿和类风湿治疗仪 |
| CN201208383Y (zh) * | 2008-05-12 | 2009-03-18 | 俞苏云 | 同步蒸气按摩器 |
| CN201431615Y (zh) * | 2009-07-20 | 2010-03-31 | 韩雪海 | 携氧中药熏蒸仪 |
| CN102670394A (zh) * | 2012-05-07 | 2012-09-19 | 林智勇 | 智能关节炎熏疗仪 |
| CN204909967U (zh) * | 2015-09-05 | 2015-12-30 | 于慧 | 护理架 |
-
2016
- 2016-04-17 CN CN201610234242.6A patent/CN105879212A/zh active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2553814Y (zh) * | 2002-07-22 | 2003-06-04 | 杨如明 | 可控式中药蒸发治疗仪 |
| JP2006174896A (ja) * | 2004-12-21 | 2006-07-06 | Matsushita Electric Ind Co Ltd | 酸素富化機 |
| CN201208383Y (zh) * | 2008-05-12 | 2009-03-18 | 俞苏云 | 同步蒸气按摩器 |
| CN201192455Y (zh) * | 2008-05-15 | 2009-02-11 | 于守杰 | 一种蒸汽型风湿和类风湿治疗仪 |
| CN201431615Y (zh) * | 2009-07-20 | 2010-03-31 | 韩雪海 | 携氧中药熏蒸仪 |
| CN102670394A (zh) * | 2012-05-07 | 2012-09-19 | 林智勇 | 智能关节炎熏疗仪 |
| CN204909967U (zh) * | 2015-09-05 | 2015-12-30 | 于慧 | 护理架 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101658631A (zh) | 一种用于治疗慢性支气管炎、肺气肿的药物 | |
| CN101670060A (zh) | 一种治疗肝气郁滞、胸痹痞满病症的中药组合物及制备方法 | |
| CN101703745B (zh) | 一种治疗胁满、胸痹病证的中药组合物及其制备方法 | |
| CN102406911A (zh) | 治疗冠心病的中药制剂 | |
| CN101579186B (zh) | 一种外用治疗风热型鼻炎的药物鼻炎枕 | |
| CN102727823B (zh) | 一种用于脑出血术后康复的药物 | |
| CN104606636B (zh) | 一种治疗抑郁症的中药组合物及其制备方法 | |
| CN101579185B (zh) | 一种外用治疗风寒型鼻炎的药物鼻炎枕 | |
| CN105879212A (zh) | 一种心脑血管疾病专用治疗仪 | |
| CN102908607B (zh) | 用于治疗慢性单纯性鼻炎的外用中药及其制备方法 | |
| CN101703682A (zh) | 治疗失眠的中药制剂 | |
| CN105125911A (zh) | 一种用于调治前列腺增生的中药组合物及其制备方法 | |
| CN104306847A (zh) | 一种六味补气胶囊及其制备工艺 | |
| CN104474256A (zh) | 一种治疗艾滋病肺部感染的口服液 | |
| CN101912566B (zh) | 治疗心悸的中药 | |
| CN102631618A (zh) | 一种治疗糖尿病的中药 | |
| CN101181509B (zh) | 一种内服治疗肺气肿的中药配方 | |
| CN102309732A (zh) | 一种治疗心律不齐的中药丸剂 | |
| CN101559134A (zh) | 一种治疗酒渣鼻的中药制剂 | |
| CN106511882A (zh) | 可治疗预防咳嗽和哮喘的中药配方及中药香囊的制备方法 | |
| CN100457177C (zh) | 一种清肺、补肾的中药保健制剂 | |
| CN102293888A (zh) | 一种治疗喘促的中药组合物 | |
| CN105902885A (zh) | 一种治疗肺癌的中药 | |
| CN105770815A (zh) | 一种含有艾叶的治疗产后虚脱的中药组合物及其制备方法 | |
| CN102885952B (zh) | 菟丝子口服液 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160824 |
|
| WD01 | Invention patent application deemed withdrawn after publication |